Do You Know Who I Am? A Look at the Devastating Effects of Alzheimer's Disease - Strategies for Early Recognition and Treatment
neuroscienceCME Compass Points
Premiere Date: Tuesday, March 9, 2010This activity offers CE credit for:
Physicians (CME)All other clinicians will receive a CME Attendance Certificate.
Credit Expiration Date: Wednesday, March 9, 2011
 | Christina J. Ansted, MPH, CCMEP Medical Program Director CME Outfitters, LLC Rockville, MD |
Since its identification in 1906 by Dr. Alois Alzheimer, Alzheimer’s disease (AD) has become known as the most common type of dementia. A slow progressing neurodegenerative disease, AD is responsible for symptoms such a memory loss and impairment, changes in behavior, and the loss of intellectual or cognitive abilities. AD is the seventh leading cause of death in the United States with more than 5.3 million people living with the disease. Data suggest that early treatment of patients with AD provides greater benefits than if treatment is delayed, and discontinuation of treatment can worsen cognitive symptoms and lead to increased total care costs. Improved education of physicians and the multidisciplinary team may be the key to improving the diagnosis of AD, which has been shown to benefit disease management and patient outcomes.
To provide clinicians with an overview of emerging therapies, strategies for early recognition, and effective management of patients with Alzheimer’s disease (AD).
At the end of this CE activity, participants should be able to:
- Recognize risk factors associated with the onset of Alzheimer’s disease (AD), and tactics for disease prevention and maintenance of brain health.
- Describe clinical tools for the identification and assessment of AD to facilitate early intervention and treatment.
- Consider available guidelines and quality measures, such as AHRQ quality measures for dementia or APA guidelines for the treatment of patients with Alzheimer’s disease and dementia, which can be incorporated into clinical practice.
Physicians and other healthcare providers interested in the management of patients with Alzheimer’s disease (AD).
Funding for this CME activity is provided by CME Outfitters, LLC.
CME Credit (Physicians):
CME Outfitters, LLC, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical
education for physicians. CME Outfitters, LLC, designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Note to Physician Assistants: AAPA accepts Category I credit from AOACCME, Prescribed credit from AAFP, and AMA Category I CME credit for the PRA from organizations accredited by ACCME.
Post-tests, credit request forms, and activity evaluations must be completed online at www.neuroscienceCME.com (click on the Testing/Certification link under the Activities tab–requires free account activation), and participants can print their certificate or statement of credit immediately (70% pass rate required). This website supports all browsers except Internet Explorer for Mac. For complete technical requirements and privacy policy, visit www.neurosciencecme.com/technical.asp.
Disclosure Declaration
It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.
Howard Bliwise, MD, (peer/content reviewer) has no disclosures to report.
Sharon Tordoff, CCMEP, (Planning Committee) has no disclosures to report.
Christina Ansted, MPH, CCMEP (Planning Committee) has no disclosures to report.
Unlabeled Use Disclosure
Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.
CME Outfitters, LLC, and the faculty do not endorse the use of any product outside of the FDA labeled indications. Medical professionals should not utilize the procedures, products, or diagnosis techniques discussed during this activity without evaluation of their patient for contraindications or dangers of use.
Questions about this activity? Call us at 877.CME.PROS (877.263.7767).
CC-001-030910-00